Giraffe Bio develops mineral-specific biochemical reagents for copper mining. The company combines AI-enabled molecular design, cell-free biology and testing on real ore samples to engineer drop-in flotation reagents that integrate into existing processing circuits without new equipment, targeting copper recovery uplifts of up to 5 percentage points where a 1-2% gain is typically considered strong. Founded in 2024 and operating from Buenos Aires and Santiago, Giraffe Bio works with mining partners globally and is extending its platform to impurity-binding depressant reagents and other minerals such as gold and silver.
1
Round
1
Industry
4
Tags
Oct 13, 2026
Latest raise
Funding activity · 1 round
Oct 13, 2026
$6.4M
Seed
Led by Orion Industrial Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
